Nuclear transport modulators and uses thereof
Abstract:
The present invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compounds of formula I or their pharmaceutically acceptable salts, and methods of using said compounds, salts and compositions in the treatment of various disorders associated with CRM1 activity.
Public/Granted literature
Information query
Patent Agency Ranking
0/0